Anti-MAGP2 antibody [EPR17581]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications)
Rabbit Recombinant Monoclonal MAGP2 antibody. Suitable for IP, WB, Flow Cyt (Intra), IHC-P and reacts with Human, Rat samples. Cited in 6 publications.
View Alternative Names
MAGP2, MFAP5, Microfibrillar-associated protein 5, MFAP-5, MP25, Microfibril-associated glycoprotein 2, MAGP-2
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-MAGP2 antibody [EPR17581] (AB203828)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling MAGP2 with ab203828 at 1/750 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/500 dilution was used as the secondary antibody.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MAGP2 antibody [EPR17581] (AB203828)
Immunohistochemical analysis of paraffin-embedded Human breast carcinoma tissue labeling MAGP2 with ab203828 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Cytoplasmic staining on Human breast carcinoma tissue is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MAGP2 antibody [EPR17581] (AB203828)
Immunohistochemical analysis of paraffin-embedded Human colon tissue labeling MAGP2 with ab203828 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Cytoplasmic staining on Human colon tissue is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-MAGP2 antibody [EPR17581] (AB203828)
MAGP2 was immunoprecipitated from 1mg of HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate with ab203828 at 1/200 dilution. Western blot was performed from the immunoprecipitate using ab203828 at 1/5000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500.
Lane 1 : HeLa whole cell lysate 10ug (Input). Lane 2 : ab203828 IP in HeLa whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab203828 in HeLa whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 seconds.
All lanes:
Immunoprecipitation - Anti-MAGP2 antibody [EPR17581] (ab203828)
Predicted band size: 20 kDa
false
- WB
Supplier Data
Western blot - Anti-MAGP2 antibody [EPR17581] (AB203828)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-MAGP2 antibody [EPR17581] (ab203828) at 1/10000 dilution
All lanes:
Human bladder lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 20 kDa
Observed band size: 25 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-MAGP2 antibody [EPR17581] (AB203828)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-MAGP2 antibody [EPR17581] (ab203828) at 1/5000 dilution
All lanes:
HeLa (Human epithelial cells from cervix adenocarcinoma) cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 20 kDa
Observed band size: 25 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-MAGP2 antibody [EPR17581] (AB203828)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-MAGP2 antibody [EPR17581] (ab203828) at 1/1000 dilution
Lane 1:
Rat kidney lysate at 10 µg
Lane 2:
Rat spleen lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 20 kDa
Observed band size: 25 kDa
false
Exposure time: 3min
- WB
CiteAb
Western blot - Anti-MAGP2 antibody [EPR17581] (AB203828)
MAGP2 western blot using anti-MAGP2 antibody [EPR17581] ab203828. Publication image and figure legend from Li, J. H., Zhu, X. X., et al., 2019, J Exp Clin Cancer Res, PubMed 31775892.
ab203828 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab203828 please see the product overview.
MFAP5 positively regulated Notch1 pathway transcription. a Heat map showed results of RNA-seq of SSP-25 and RBE transformed sh-control, sh-MFAP5–1# and sh-MFAP5–2#. b, c GSEA results showed down-regulation of Notch pathway in cells transfected sh-MFAP5 compared with sh-Control. d, e RT-PCR results showed the mRNA level of genes in NOTCH1 pathway after transfected sh-MFAP5 in ICC cell lines. f, g Western blot analysis of Notch1 pathway target genes in sh-MFAP5 and sh-Control cells (f) and co-culture with recMFAP5 and control cells (G, each "+" represented 50μg/ml recMFAP5). h, i Co-IP results showed that MFAP5 could bind directly with NOTCH1. *p < 0.05,**p < 0.01,***p<0.001
false
Related conjugates and formulations (1)
-
Anti-MAGP2 antibody [EPR17581] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:6032 PubMed40595652
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 13:8728 PubMed37253753
2023
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 13:e1193 PubMed36738110
2023
Applications
Unspecified application
Species
Unspecified reactive species
eLife 10: PubMed33480357
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 11:1596-1605 PubMed32047565
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research 38:476 PubMed31775892
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com